These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8080821

  • 1. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M, Guinot P, Hosford D, Braquet PG.
    Adv Pharmacol; 1994; 28():81-167. PubMed ID: 8080821
    [No Abstract] [Full Text] [Related]

  • 2. Inflammatory membrane-derived lipids and their antagonists.
    Guinot P.
    Clin Rev Allergy; 1994; 12(4):305-7. PubMed ID: 7743459
    [No Abstract] [Full Text] [Related]

  • 3. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.
    Anderson BO, Bensard DD, Harken AH.
    Surg Gynecol Obstet; 1991 May; 172(5):415-24. PubMed ID: 1851337
    [Abstract] [Full Text] [Related]

  • 4. [The significance of platelet activating factor and its antagonists in bronchial asthma].
    Beume R, Kilian U.
    Med Klin (Munich); 1989 Jun 15; 84(6):286-93. PubMed ID: 2547143
    [No Abstract] [Full Text] [Related]

  • 5. [Platelet-activating factor (PAF) receptor-related pathophysiology].
    Ishii S, Shimizu T.
    Tanpakushitsu Kakusan Koso; 1999 Jun 15; 44(8 Suppl):1068-74. PubMed ID: 10396985
    [No Abstract] [Full Text] [Related]

  • 6. Recent development of platelet-activating factor antagonists.
    Shen TY, Hussaini I, Hwang SB, Chang MN.
    Adv Prostaglandin Thromboxane Leukot Res; 1989 Jun 15; 19():359-62. PubMed ID: 2546389
    [No Abstract] [Full Text] [Related]

  • 7. [Platelet activating factor and platelet activating factor antagonists. New methods in asthma therapy?].
    Uhl D.
    Med Monatsschr Pharm; 1989 Jun 15; 12(6):170-2. PubMed ID: 2544789
    [No Abstract] [Full Text] [Related]

  • 8. [Platelet-activating factor antagonists and asthma].
    Wang YY, Li CL.
    Sheng Li Ke Xue Jin Zhan; 1992 Apr 15; 23(2):136-40. PubMed ID: 1329195
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock.
    Sánchez Crespo M, Fernández-Gallardo S.
    J Lipid Mediat; 1991 Apr 15; 4(2):127-43. PubMed ID: 1659463
    [No Abstract] [Full Text] [Related]

  • 10. Effect of platelet-activating factor on platelets and vascular endothelium.
    Braquet P, Bourgain R, Mencia-Huerta JM.
    Semin Thromb Hemost; 1989 Apr 15; 15(2):184-96. PubMed ID: 2546255
    [No Abstract] [Full Text] [Related]

  • 11. Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury.
    Camussi G.
    Lab Invest; 1994 Apr 15; 70(4):435-6. PubMed ID: 8176883
    [No Abstract] [Full Text] [Related]

  • 12. [Function of platelet activating factor in asthma].
    Ukena D, Sybrecht GW.
    Dtsch Med Wochenschr; 1988 Oct 21; 113(42):1651-6. PubMed ID: 2846251
    [No Abstract] [Full Text] [Related]

  • 13. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
    Terashita Z, Imura Y, Nishikawa K, Sumida S.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Oct 21; 15():715-7. PubMed ID: 3004156
    [No Abstract] [Full Text] [Related]

  • 14. Platelet-activating factor antagonists as therapeutic strategy in sepsis.
    Dhainaut JF, Mira JP, Brunet F.
    Prog Clin Biol Res; 1994 Oct 21; 388():277-93. PubMed ID: 7831364
    [No Abstract] [Full Text] [Related]

  • 15. Interspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist.
    Elder CA, Modi MW.
    Drug Metab Dispos; 1995 Jul 21; 23(7):776-8. PubMed ID: 7587967
    [No Abstract] [Full Text] [Related]

  • 16. [Study of platelet activating factor by using mouse ontogenic technology].
    Kume K, Shimizu K, Ishii S.
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec 21; 19(6):572-5. PubMed ID: 9081720
    [No Abstract] [Full Text] [Related]

  • 17. ABT-299, a potent antagonist of platelet activating factor.
    Summers JB, Albert DH, Davidsen SK, Conway RG, Holms JH, Magoc TJ, Luo G, Tapang P, Rhein DA, Carter GW.
    Adv Prostaglandin Thromboxane Leukot Res; 1995 Dec 21; 23():475-7. PubMed ID: 7732895
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of platelet activating factor on blood platelets].
    Fu JM.
    Sheng Li Ke Xue Jin Zhan; 1989 Jan 21; 20(1):40-4. PubMed ID: 2549618
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury.
    Prescott SM, McIntyre TM, Zimmerman G.
    J Clin Invest; 1999 Oct 21; 104(8):1019-20. PubMed ID: 10525039
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.